加斯特罗丁:一个全面的药理学审查
Yulin Wang1,2, Mengting Bai1,2, Xian Wang1,2
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Naunyn-Schmiedeberg's archives of pharmacology
|January 2, 2024
概括
来自天马的胃素 (GAS) 显示出神经,心血管和肝脏疾病的显著治疗潜力. 微生物合成和衍生品为其开发和应用提供了有前途的途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 传统中国医药 传统中国医药
背景情况:
- 天马 (Gastrodia elata Blume) 是一种传统的中医药.
- 胃素 (GAS) 是天马的主要活性化合物.
- GAS表现出显著的药理活动.
研究的目的:
- 审查Gastrodin (GAS) 的提取,合成,药理作用和衍生物.
- 探索GAS的未来发展机会.
- 巩固目前对GAS用于治疗应用的研究.
主要方法:
- 关于Gastrodin (GAS) 的研究文献综述.
- 提取和合成方法的分析,包括微生物生产.
- 检查药理学数据和衍生研究.
主要成果:
- 微生物合成为GAS提供了一个有前途的生产方法.
- GAS在治疗神经,心血管,内分泌和肝脏疾病方面表现出有效性.
- 关键的药理作用包括抗炎,抗氧化,神经保护和止痛特性,通过Nrf2,NF-κB,PI3K/AKT和AMPK等途径进行介导.
- GAS衍生品和GAS-PU生物材料表明了扩大应用潜力.
结论:
- 加斯特罗丁 (GAS) 在多种疾病领域具有广泛的治疗潜力.
- 对天然气衍生品和新型应用的进一步研究是有必要的.
- 在开发新疗法方面,GAS具有显著价值.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
329
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
329
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
444
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
444
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
486
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
486
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
165
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
165
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
262
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
262
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88


